Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Real-world treatment patterns and outcomes in severe acute exacerbations of chronic obstructive pulmonary disease: an observational study.

Created on 12 Nov 2026

Authors

Lilla Árvai-Horváth, Piroska Manzel, István Méhész, Dalma Wessják, Dávid Á Karádi, Szabolcs Baglyas, András Lorx, Luca Valkó

Published in

BMC pulmonary medicine. Volume 26. Issue 1. Aug 14, 2026. Epub Aug 14, 2026.

Abstract

Chronic obstructive pulmonary disease (COPD) represents a significant healthcare burden. Acute exacerbation (AECOPD) episodes frequently require hospitalization, and a number of these involve intensive care (ICU) unit admission. Noninvasive ventilation (NIV) use is associated with superior outcome, despite this, real-world data indicate that NIV remains underutilized. Our aim was to characterize NIV utilization for severe AECOPD patients admitted to participating Hungarian ICUs.
We conducted a 2-month long prospective observational study of AECOPD patients in ICUs and collected national health registry data for parallel validation.
In five participating ICUs 27 (4.86%) out of 555 screened patients were recruited. Patients were predominantly older, overweight, and had several comorbidities. Hypercapnia, elevated bicarbonate levels and pneumonia were common at admission. ICU mortality was 22.2%, and in-hospital mortality rate reached 37%, compared to a predicted 55 (25-73%) ICU mortality. NIV was used in most patients, however, only 25.9% received NIV exclusively. NIV was the initial ventilation type in 55.6% of cases, but early NIV failure rate was 46.7%. Difficult weaning was reported in 30% of patients. NIV failure was associated with longer ICU stay and increased hospital mortality. National Health Fund data confirmed overall low NIV use, with only 4.8% of COPD patients receiving this therapy.
Severe AECOPD in Hungarian ICUs is currently associated with low NIV utilization, high NIV failure rate and considerable hospital mortality. Future studies should focus on appropriate patient selection, initial NIV application and therapy optimization.

PMID:
43015760
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement